BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Quick Stats
Jul 02, 202662.2
AI Score
BUY0.87
Volume Ratio
Aug 04, 2026
Next Earnings
18
+ve Days (30d)
12
-ve Days (30d)
BBIO Stock Summary
Last updated Jul 02, 2026
BBIO is currently trading at $77.19, positioned above its 200-day moving average of $68.4, indicating a long-term uptrend. The stock has a 52-week range of $42.0901 to $84.94.
Technical Analysis: The 50-day moving average stands at $68.75, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 73.387, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.069, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BBIO at 62.2/100 with a BUY recommendation.
BBIO (BridgeBio Pharma, Inc. Common Stock) Indicators
Last updated Jul 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 73.387 |
| CMF (20) | -0.069 |
| ROC (10) | 14.542 |
| ADX (14) | 19.027 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.66 |
| AROONOSC (14) | 64.286 |
| WILLAMS %R (14) | -0.6 |
| MFI (14) | 87.549 |
BBIO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BBIO Price vs Max Options Open Interest
BBIO Max Change In Options Open Interest
BBIO Options - Sort by Max open Interest (near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BBIO Daily Out of Money Options - Sort by Max open Interest (near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BBIO Daily In the Money Options - Sort by Max open Interest (near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BBIO Most Active Options by Volume(near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BridgeBio Pharma, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
BBIO Moving Averages Analysis
BridgeBio Pharma, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 02, 2026
BridgeBio Pharma, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 02, 2026
BBIO (BridgeBio Pharma, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jul 02, 2026
| Days | MA |
|---|---|
| 10 | 71.13 |
| 20 | 69.25 |
| 30 | 68.54 |
| 50 | 68.75 |
| 100 | 70.12 |
| 200 | 68.4 |
BBIO Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 14.6 billion |
| Earnings/Share ($) | -3.74 |
| Net Proft Margin (%) | -1.2442 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.18 |
| EPS Estimate Next Year ($) | 0.5273 |
| WallStreet Target Price ($) | 102.2778 |
| Most Recent Quarter |